Home » Newsletter Only

Newsletter Only

Featured posts

Study Finds that Marijuana and Hallucinogen Use Reach Historic Highs Among U.S. Adults

Use of marijuana and hallucinogens among adults 19 to 50 reached an all-time high in 2022, according to the Monitoring the Future Panel Study, which is sponsored annually by the National Institutes of Health. Furthermore, the study found that alcohol use among adults...

Staying Current: The Drug Testing Market Shifts to Oral Fluid

By Bill Current This article was written by Bill Current of the Current Consulting Group (CCG) on behalf of Premier Biotech for publication by NDASA. For further information about the subjects covered in this article, please email Bill at...

Part 40 Myths and Urban Legends: Misconceptions About DOT’s Oral Fluid Final Rule

By Patrice M. Kelly, JD, Senior Policy Executive Advisor National Drug & Alcohol Screening Association This is the first in a series of articles I am writing to dispel the “myths and urban legends” surrounding the U.S. Department of Transportation (DOT) drug and...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts